On the other hand, the PI3K/Akt/mTOR pathway regulates the metabolic phenotype of microglia and glia‐mediated neuroinflammation via altering energy metabolism remodeling48 and mediating the production of nitric oxide,49, 50 thereby triggering microglial‐associated depression pathogenesis. Here, AKT1 is linked to depressive symptom measurement.